ARCHIVES

Program Project Payline Is 125; Budget Cuts Will Allow NCI To Fund 49 Competing P01s

This article is from The Cancer Letter archive.

Vol. 18 No. 09 | February 28, 1992

Download PDF Visit The Full Archive

Related Articles

Center Grant Review Tougher, Yarbro Insists

May 23, 1975

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

December 28, 2012

Questions Still Surround 88 BCDDP Patients Found With Minimal Cancer; DCCR Asks for Another Review

October 28, 1977

NCI To Fund More SPORE Grants In FY95 Recopetition

March 11, 1994

In Brief: Daniel Ihde Named NCI Deputy Director; Roper Is Carter consultant; Another Honor For Forei

February 8, 1991

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

October 28, 2011